GSK plc

Industry

  • Pharmaceuticals
    • Vaccines
  • Digital Health
    • Disease Management
  • Biotechnology

Other Names/Subsidiaries

  • Affinivax
  • Bellus Health
  • Biovesta
  • Block Drug
  • Cellzome
  • Corixa
  • Domantis
  • Europharm Distributie
  • Elsie Biotechnologies
  • Genelabs Technologies
  • GlaxoSmithKline
  • GlycoVaxyn
  • Human Genome Sciences
  • ID Biomedical
  • IDRx
  • Laboratoire Pharmaceutique Algerien
  • Laboratorios Dermatologicos Darier
  • Laboratorios Phoenix
  • Maxinutrition
  • ReiThera
  • Sitari Pharmaceuticals
  • Stiefel Laboratories
  • Sierra Oncology
  • TESARO
See more in Biomedtracker

Latest on GSK plc

Pink Sheet

Recent And Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Scrip

Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADC

 
• By Joseph Haas, Lisa Takagi, Sushmita Panda, and Xu Hu

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. SunRock, Escugen Partner To Develo

Scrip

Gilead’s Yeztugo Gets US Approval For Twice-Yearly PrEP

 
• By Alexandra Shimmings

Gilead Sciences has obtained US approval for its HIV-1 capsid inhibitor, lenacapavir, as a twice-yearly subcutaneous injection to prevent HIV infection – an endorsement that should secure the product

Pink Sheet

Blenrep’s Comeback Continues As England Becomes First To Fund Drug

 
• By Eliza Slawther

NICE, the health technology assessment (HTA) institute for England, has provisionally recommended that GSK’s Blenrep (belantamab mafodotin) be funded via the National Health Service for use in combina